Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/25
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 07/27/21
End: 02/21/22
Due: 02/21/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain | NCT05265052 | 3D Medicines | user2@example.com | None | 2025-12-31 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Study of 3D189 in Patients With Hematologic Malignancies | NCT05320809 | 3D Medicines | user2@example.com | None | 2022-08-01 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| Phase 1 Study of 3D229 in Healthy Subjects | NCT04941313 | 3D Medicines | user2@example.com | None | 2021-07-27 | 2022-02-21 | 2023-02-21 | - | - | 2025-07-14 |